"MicroILCs: Deciphering how the gut Microbiota influences Innate Lymphoid Cells in obesity"""

Project Information

MicroILCs

Grant agreement ID: 890545

DOI 10.3030/890545

Project closed

EC signature date 4 March 2020

Start date 1 January 2021

End date 22 April 2023

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost € 160 932,48

EU contribution € 160 932,48

Coordinated by

AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
Spain

Publications

Peer reviewed articles (2)

The gut microbiota as a versatile immunomodulator in obesity and associated metabolic disorders

Author(s): Liébana-García R, Olivares M, Bullich-Vilarrubias C, López-Almela I, Romaní-Pérez M, Sanz Y
Published in: Best Pract Res Clin Endocrinol Metab, 2021, ISSN 1521-690X
Publisher: Bailliere Tindall And Cassell
DOI: 10.1016/j.beem.2021.101542

Intestinal group 1 innate lymphoid cells drive macrophage-induced inflammation and endocrine defects in obesity and promote insulinemia.

Author(s): Liébana-García R, Olivares M*, Francés-Cuesta C, Rubio T, Rossini V, Quintas G, Sanz Y
Published in: Gut microbes, 2023, ISSN 1949-0976
Publisher: Landes Bioscience
DOI: 10.1080/19490976.2023.2181928

Other (1)

Tiny contributors to severe obesity inside the gut

Author(s): Y. Sanz, Olivares M
Published in: Gut, 2022, ISSN 0017-5749
Publisher: BMJ Publishing Group
DOI: 10.1136/gutjnl-2021-326781